$AGL

Levi & Korsinsky notifies Agilon Health shareholders of securities fraud lawsuit over false 2025 guidance; lead plaintiff deadline March 2, 2026.

Law Offices of Frank R. Cruz files class actions against $AGHI, $FRMI, $VRNS, $ARDT for materially false statements. Lead plaintiff deadlines March 2-9, 2026.

Agilon Health faces securities class action over alleged 2025 guidance misstatements. Lead plaintiff deadline is March 2, 2026 for investors with losses.

Class action lawsuit filed against agilon health for allegedly making false statements about 2026 financial guidance and misrepresenting risk reduction initiatives' financial impact.

Agilon Health faces class action lawsuit over false 2025 financial guidance. Lead plaintiff deadline set for March 2, 2026; eligible investors urged to apply.

Pomerantz Law Firm sues Agilon Health for securities fraud following CEO resignation and 51% stock decline after guidance suspension.

Rosen Law Firm seeks lead plaintiff for PomDoctor securities class action by April 7, 2026. Investors alleging losses from fraudulent promotion and misleading statements can apply.

Rosen Law Firm sues Richtech Robotics for allegedly false Microsoft partnership claims. Investors must act by April 3, 2026 deadline to join litigation.

Rosen Law Firm urges Agilon Health investors with losses over $100,000 to join securities class action before March 2026 deadline. Lawsuit alleges false financial guidance.

Class action lawsuit filed against agilon health for allegedly making false 2026 guidance claims and overstating financial benefits of risk-reduction initiatives, harming investors.

Agilon Health faces securities lawsuit over allegedly false 2025 guidance. Stock fell 51.6% after CEO termination and guidance suspension on August 4.

Class action securities fraud lawsuits filed against Klarna, Agilon Health, and Fermi. Investor lead plaintiff deadlines range from February 20 to March 6, 2026.

Robbins LLP files class action suit against Agilon Health for allegedly issuing unachievable 2025 guidance and overstating strategic initiatives, following 50% stock decline.

Class action lawsuit filed against agilon health for allegedly making false 2026 guidance claims and overstating benefits of risk reduction initiatives, affecting investors from February-August 2025.

Agilon Health faces securities class action lawsuit alleging materially false 2026 financial guidance and misleading statements about risk mitigation. Investors from February-August 2025 may participate.

Rosen Law Firm filed a securities class action against Agilon Health for allegedly making false 2025 guidance statements. Investors harmed between February-August 2025 can participate; deadline March 2, 2026.

AGL faces securities fraud allegations over false 2025 guidance. Stock plunged 51.5% after guidance suspension; investors have until March 2026 deadline to join class action.

Four companies face securities fraud lawsuits alleging false statements to investors. Shareholders have until March 2026 to become lead plaintiffs in the class actions.